PMID: 4266586Apr 1, 1973

Calcium uptake and associated adenosine triphosphatase activity of isolated platelet membranes

The Journal of General Physiology
L S RobbleeF A Belamarich


A platelet subcellular fraction, sedimenting between 14,000 and 40,000 g and consisting primarily of membrane vesicles, accumulates up to 200-400 nmoles calcium/mg protein in the presence of ATP and oxalate. Steady-state levels of calcium accumulation are attained in 40-60 min. Calcium uptake requires adenosine triphosphate (ATP), is enhanced by oxalate, and is accompanied by the release of inorganic phosphate. Calcium accumulation and phosphate release require magnesium and are inhibited by Salyrgan (10 microM) and adenosine diphosphate (ADP) (1 mM), but not by ouabain (0.1 mM). The ATPase activity is stimulated by low concentrations of calcium (5-10 microM) and is inhibited by 2 mM EGTA. Electron microscopic histochemistry using lead nitrate to precipitate released phosphate results in lead precipitates localized primarily at the inner surface of membrane vesicles. These results provide evidence for a membrane ATPase that is stimulated by low concentrations of calcium and may be involved in the transport of calcium across the membrane. It is postulated that the observed calcium uptake activity is an in vitro manifestation of a calcium extrusion pump in the intact platelet.


Jul 1, 1973·Microvascular Research·L S RobbleeF A Belamarich
Jan 1, 1981·Neuroscience and Biobehavioral Reviews·R D Myers, D H Ross
Jan 1, 1982·Pharmacology & Therapeutics·N G Ardlie
Jan 1, 1990·Comparative Biochemistry and Physiology. A, Comparative Physiology·D W PorterW Kaczmarczyk
Jun 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·G A Rodan, M B Feinstein
Jul 1, 1977·The Journal of Cell Biology·S E Hitchcock
Jul 1, 1974·The Journal of General Physiology·A M ChambautJ Hanoune
Jan 1, 1976·Clinical and Experimental Pharmacology & Physiology·G Forget, S Heisler
May 1, 1978·Biological Reviews of the Cambridge Philosophical Society·R M Case
Mar 1, 1975·Acta Physiologica Scandinavica·J T Russell, N A Thorn
Apr 28, 1978·Annals of the New York Academy of Sciences·L Moore, I Pastan
Jan 1, 1974·CRC Critical Reviews in Biochemistry·T D Pollard, R R Weihing
Oct 1, 1977·Thrombosis Research·L B KornsteinD Shepro
Mar 1, 1979·Prostaglandins and Medicine·A M ButlerJ G White
Nov 1, 1978·Prostaglandins and Medicine·J M GerrardJ G White
Oct 1, 1978·Thrombosis Research·W C Horne, E R Simons
Apr 30, 1984·Biochemical and Biophysical Research Communications·G C White
Nov 15, 1979·FEBS Letters·E Zubrzycka-GaarnH E Osińska
Jan 1, 1977·The American Journal of Physiology·R A JanisE E Daniel


Aug 2, 1969·Nature·B E StatlandJ G White
Oct 29, 1968·Biochimica Et Biophysica Acta·S Matsushita, I D Raacke
Aug 1, 1971·Journal of Neurochemistry·I Diamond, A L Goldberg
Nov 1, 1968·British Journal of Pharmacology·W W Douglas
Jan 1, 1968·Progress in Biophysics and Molecular Biology·S Ebashi, M Endo
Feb 1, 1971·The Journal of General Physiology·Y N ChaK S Lee
Jun 15, 1966·Experientia·H J Schatzmann
Feb 1, 1961·The Journal of Biophysical and Biochemical Cytology·J H LUFT
Mar 1, 1963·The Journal of General Physiology·A WEBERI REISS
Mar 25, 1960·Biochimica Et Biophysica Acta·H MUELLER

Related Concepts

Calcium [EPC]
Adenosine Diphosphate Measurement
Tissue Membrane
Magnesium Measurement
Adenosine Triphosphatases

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.